Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BridgeBio Pharma, Inc. (BBIO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-K10-K
Total revenues  69.78.240.60.00.0
            Revenue growth  745.1%-79.7%   
Cost of goods sold  2.7478.0303.20.00.0
Gross profit  67.0-469.8-262.70.00.0
            Gross margin  96.1%-5694.7%-647.6%  
Selling, general and administrative   [+]643.64.73.643.613.3
Research and development     140.130.6
Equity in earnings     -0.3 
Other operating expenses   -4.7-3.6-19.3 
EBITDA   [+]-573.3-468.3-261.8  
            EBITDA margin  -822.4%-5677.0%-645.5%  
Depreciation  0.71.50.9  
EBITA  -574.0-469.8-262.7-164.6-43.9
            EBITA margin  -823.4%-5694.7%-647.6%  
Amortization of intangibles  2.6    
EBIT   [+]-576.6-469.8-262.7-164.6-43.9
            EBIT margin  -827.1%-5694.7%-647.6%  
Non-recurring items   [+] 4.73.619.3 
Interest expense, net   [+]-1.1-4.0-8.90.50.0
Other income (expense), net   [+]608.1507.1266.1353.987.7
Pre-tax income  0.00.00.0169.543.8
Income taxes  0.00.00.00.00.0
            Tax rate     0.0%0.0%
Minority interest     38.713.3
Net income  0.00.00.0-130.7-30.6
            Net margin  0.0%0.0%0.0%  
   
Basic EPS   [+]$0.00$0.00$0.00($2.12)($1.00)
Diluted EPS   [+]$0.00$0.00$0.00($2.12)($1.00)
   
Dividends per share   [+]    $0.04
   
Shares outstanding (basic)   [+]144.4118.0105.161.830.6
Shares outstanding (diluted)   [+]144.4118.0105.161.830.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy